Genzola, Angel A.

HRN: 22-15-48  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/19/2022
CEFUROXIME 1.5GM (VIAL)
11/19/2022
11/26/2022
IVTT
1.5g Then 750mg
Q8h
Postpartum Infection
11/20/2022
CEFUROXIME 1.5GM (VIAL)
11/20/2022
11/25/2022
IV
1.5g
Q8
Postpartum Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: